Since DAPK-1 is essential for the death and loss of neuronal cells under various stimuli, DAPK-1 inhibitors may offer a novel therapeutic strategy for neurological diseases such as ischemia and Alzheimer’s disease [101]. This evidence concerns the gene DAPK1 and Alzheimer disease.